This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial) | MicrobiomeTrials
← Back to trials NCT07163143
Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial) Recruiting PHASE3 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-10-12Est. Completion: 2028-11
Enrollment target: 784 participantsLocations National University of Medical Sciences, Islamabad, Pakistan Clinical HIV Research Unit, Wits Health Consortium, Johannesburg, South Africa The Aurum Institute, Johannesburg, South Africa Bulawayo City Health, Bulawayo, Zimbabwe Other microbiome trials you might be interested in Mycobacterium Infections Tuberculosis, Multidrug-Resistant Latent Tuberculosis Tuberculosis Extensively Drug-Resistant Tuberculosis
Background:
\- Tuberculosis (TB) is an infectious disease that affects numerous people worldwide. Researchers are inter…
Bethesda, United States
Rifampicin-Resistant Pulmonary Tuberculosis Multidrug-Resistant Pulmonary Tuberculosis
This is a Phase 3, randomized, open-label, active-controlled, multicenter trial evaluating the efficacy, safety, and tol…
Beijing, China Est. completion Sep 29, 2028
Tuberculosis
The goal of this Phase II, multicenter, open-label, randomized controlled trial is to evaluate the efficacy and safety o…
Fuzhou, China Est. completion Nov 30, 2027